• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全长CtBP1表达缺失增强了人类黑色素瘤的侵袭潜能。

Loss of full length CtBP1 expression enhances the invasive potential of human melanoma.

作者信息

Winklmeier Andreas, Poser Ina, Hoek Keith S, Bosserhoff Anja K

机构信息

Institute of Pathology, University Regensburg, 93053 Regensburg, Germany.

出版信息

BMC Cancer. 2009 Feb 12;9:52. doi: 10.1186/1471-2407-9-52.

DOI:10.1186/1471-2407-9-52
PMID:19216735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2650708/
Abstract

BACKGROUND

The C-terminal binding protein 1 (CtBP1) is a known co-repressor of gene transcription. We recently revealed that CtBP1 expression is lost in melanoma cells and melanoma inhibitory activity (MIA) expression is subsequently increased. The present study was performed to evaluate a more general role of CtBP1 in human melanoma and identify further CtBP1-regulated target genes.

METHODS

Sequence analysis and expression profile of CtBP1 in melanoma cell lines were done by PCR. Boyden Chamber assays and co-immunoprecipitation were performed to investigate the functional role of CtBP1. Gene expression analysis and micro array data were used to define target genes.

RESULTS

Interestingly, we detected an alternative splice product of CtBP1 with unknown function whose expression is induced at reduction of full length CtBP1. Overexpression of full length CtBP1 in melanoma cells had no effect on cell proliferation but did influence cell migration and invasiveness. To understand the effect of CtBP1 we identified putative LEF/TCF target genes found to be strongly expressed in melanoma using DNA microarray analysis. We focused on fourteen genes not previously associated with melanoma. Detailed analysis revealed that most of these were known to be involved in tumor metastasis. Eleven genes had expression profiles associated with melanoma cell invasiveness.

CONCLUSION

In summary, this study revealed that reduction of CtBP1 expression is correlated with migratory, invasive potential of melanoma cells.

摘要

背景

C 末端结合蛋白 1(CtBP1)是一种已知的基因转录共抑制因子。我们最近发现,黑色素瘤细胞中 CtBP1 的表达缺失,随后黑色素瘤抑制活性(MIA)表达增加。本研究旨在评估 CtBP1 在人类黑色素瘤中的更广泛作用,并确定 CtBP1 调控的其他靶基因。

方法

通过聚合酶链反应(PCR)对黑色素瘤细胞系中 CtBP1 的序列分析和表达谱进行检测。采用 Boyden 小室实验和免疫共沉淀法研究 CtBP1 的功能作用。利用基因表达分析和微阵列数据确定靶基因。

结果

有趣的是,我们检测到一种功能未知的 CtBP1 可变剪接产物,其表达在全长 CtBP1 减少时被诱导。在黑色素瘤细胞中过表达全长 CtBP1 对细胞增殖没有影响,但确实影响细胞迁移和侵袭能力。为了解 CtBP1 的作用,我们通过 DNA 微阵列分析鉴定了在黑色素瘤中强烈表达的假定 LEF/TCF 靶基因。我们关注了 14 个以前与黑色素瘤无关的基因。详细分析表明,其中大多数已知参与肿瘤转移。11 个基因的表达谱与黑色素瘤细胞侵袭性相关。

结论

总之,本研究表明 CtBP1 表达的降低与黑色素瘤细胞的迁移、侵袭潜能相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad37/2650708/45eb91ffa595/1471-2407-9-52-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad37/2650708/2f98fdf7963f/1471-2407-9-52-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad37/2650708/0b190bde9625/1471-2407-9-52-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad37/2650708/bcae1b7b6568/1471-2407-9-52-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad37/2650708/45eb91ffa595/1471-2407-9-52-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad37/2650708/2f98fdf7963f/1471-2407-9-52-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad37/2650708/0b190bde9625/1471-2407-9-52-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad37/2650708/bcae1b7b6568/1471-2407-9-52-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad37/2650708/45eb91ffa595/1471-2407-9-52-4.jpg

相似文献

1
Loss of full length CtBP1 expression enhances the invasive potential of human melanoma.全长CtBP1表达缺失增强了人类黑色素瘤的侵袭潜能。
BMC Cancer. 2009 Feb 12;9:52. doi: 10.1186/1471-2407-9-52.
2
MicroRNA-137 targets carboxyl-terminal binding protein 1 in melanoma cell lines.miRNA-137 靶向黑色素瘤细胞系中的羧基末端结合蛋白 1。
Int J Biol Sci. 2011 Jan 27;7(1):133-7. doi: 10.7150/ijbs.7.133.
3
C-Terminal Binding Protein 1 Modulates Cellular Redox via Feedback Regulation of MPC1 and MPC2 in Melanoma Cells.C 端结合蛋白 1 通过反馈调节黑素瘤细胞中的 MPC1 和 MPC2 来调节细胞氧化还原。
Med Sci Monit. 2018 Oct 25;24:7614-7624. doi: 10.12659/MSM.912735.
4
Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells.鉴定并描述一种新型靶向黑色素瘤细胞 CtBP1/BARS 的有效抑制剂。
J Exp Clin Cancer Res. 2024 May 6;43(1):137. doi: 10.1186/s13046-024-03044-5.
5
CtBP1 is expressed in melanoma and represses the transcription of p16INK4a and Brca1.CtBP1 在黑色素瘤中表达,并抑制 p16INK4a 和 Brca1 的转录。
J Invest Dermatol. 2013 May;133(5):1294-301. doi: 10.1038/jid.2012.487. Epub 2013 Jan 10.
6
Down-regulation of COOH-terminal binding protein expression in malignant melanomas leads to induction of MIA expression.恶性黑色素瘤中羧基末端结合蛋白表达的下调导致黑色素瘤抑制抗原表达的诱导。
Cancer Res. 2002 Oct 15;62(20):5962-6.
7
Expression of CtBP family protein isoforms in breast cancer and their role in chemoresistance.CtBP 家族蛋白异构体在乳腺癌中的表达及其在化疗耐药中的作用。
Biol Cell. 2010 Jan;103(1):1-19. doi: 10.1042/BC20100067.
8
ZNF623 contributes to breast carcinoma progress by recruiting CtBP1 to regulate NF-κB pathway.ZNF623 通过招募 CtBP1 来调节 NF-κB 通路促进乳腺癌的进展。
Biochem Biophys Res Commun. 2024 Oct 8;728:150314. doi: 10.1016/j.bbrc.2024.150314. Epub 2024 Jun 25.
9
Transcriptional down-regulation of Brca1 and E-cadherin by CtBP1 in breast cancer.CtBP1 对乳腺癌中 Brca1 和 E-cadherin 的转录下调作用。
Mol Carcinog. 2012 Jun;51(6):500-7. doi: 10.1002/mc.20813. Epub 2011 Jun 16.
10
MicroRNA485-3p negatively regulates the transcriptional co-repressor to control the oncogenic process in osteosarcoma cells.miR-485-3p 负调控转录共抑制因子 以控制骨肉瘤细胞中的致癌过程。
Int J Biol Sci. 2018 Aug 6;14(11):1445-1456. doi: 10.7150/ijbs.26335. eCollection 2018.

引用本文的文献

1
Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells.鉴定并描述一种新型靶向黑色素瘤细胞 CtBP1/BARS 的有效抑制剂。
J Exp Clin Cancer Res. 2024 May 6;43(1):137. doi: 10.1186/s13046-024-03044-5.
2
CLK2 Expression Is Associated with the Progression of Colorectal Cancer and Is a Prognostic Biomarker.CLK2 表达与结直肠癌的进展相关,是一种预后生物标志物。
Biomed Res Int. 2022 Jul 7;2022:7250127. doi: 10.1155/2022/7250127. eCollection 2022.
3
Conservation of Epithelial-to-Mesenchymal Transition Process in Neural Crest Cells and Metastatic Cancer.

本文引用的文献

1
In vivo switching of human melanoma cells between proliferative and invasive states.人黑色素瘤细胞在增殖状态和侵袭状态之间的体内转换。
Cancer Res. 2008 Feb 1;68(3):650-6. doi: 10.1158/0008-5472.CAN-07-2491.
2
Role of the PLDLS-binding cleft region of CtBP1 in recruitment of core and auxiliary components of the corepressor complex.CtBP1的PLDLS结合裂隙区域在共抑制复合物核心及辅助成分募集过程中的作用。
Mol Cell Biol. 2008 Jan;28(1):269-81. doi: 10.1128/MCB.01077-07. Epub 2007 Oct 29.
3
Role of NAD binding and catalytic residues in the C-terminal binding protein corepressor.
神经嵴细胞和转移性癌症中上皮-间充质转化过程的保守性。
Cells Tissues Organs. 2021;210(3):151-172. doi: 10.1159/000516466. Epub 2021 Jul 2.
4
Membrane Transporters and Channels in Melanoma.黑色素瘤中的膜转运蛋白与通道
Rev Physiol Biochem Pharmacol. 2021;181:269-374. doi: 10.1007/112_2020_17.
5
C-terminal of E1A binding protein 1 enhances the migration of gastric epithelial cells and has a clinicopathologic significance in human gastric carcinoma.E1A结合蛋白1的C末端增强胃上皮细胞的迁移并在人胃癌中具有临床病理意义。
Onco Targets Ther. 2019 Jul 2;12:5189-5200. doi: 10.2147/OTT.S203479. eCollection 2019.
6
C-terminal of E1A binding protein 2 promotes the malignancy of osteosarcoma cells via JAK1/Stat3 signaling.E1A结合蛋白2的C末端通过JAK1/Stat3信号通路促进骨肉瘤细胞的恶性增殖。
J Cell Commun Signal. 2020 Mar;14(1):67-76. doi: 10.1007/s12079-019-00523-9. Epub 2019 Jun 19.
7
miR-708-5p: a microRNA with emerging roles in cancer.miR-708-5p:一种在癌症中发挥新作用的微小RNA。
Oncotarget. 2017 Aug 1;8(41):71292-71316. doi: 10.18632/oncotarget.19772. eCollection 2017 Sep 19.
8
The Role of CtBP1 in Oncogenic Processes and Its Potential as a Therapeutic Target.CtBP1在致癌过程中的作用及其作为治疗靶点的潜力。
Mol Cancer Ther. 2017 Jun;16(6):981-990. doi: 10.1158/1535-7163.MCT-16-0592.
9
Silencing of CtBP1 suppresses the migration in human glioma cells.CtBP1基因沉默抑制人胶质瘤细胞的迁移。
J Mol Histol. 2016 Jun;47(3):297-304. doi: 10.1007/s10735-016-9678-z. Epub 2016 May 9.
10
Genome profiling of ERBB2-amplified breast cancers.ERBB2 扩增型乳腺癌的基因组分析。
BMC Cancer. 2010 Oct 8;10:539. doi: 10.1186/1471-2407-10-539.
NAD结合和催化残基在C末端结合蛋白共抑制因子中的作用。
FEBS Lett. 2007 Nov 13;581(27):5241-6. doi: 10.1016/j.febslet.2007.10.011. Epub 2007 Oct 12.
4
Changes in the distribution pattern of Claudin tight junction proteins during the progression of mouse skin tumorigenesis.紧密连接蛋白Claudin在小鼠皮肤肿瘤发生进展过程中的分布模式变化。
BMC Cancer. 2007 Oct 18;7:196. doi: 10.1186/1471-2407-7-196.
5
Involvement of CtBP1 in the transcriptional activation of the MDR1 gene in human multidrug resistant cancer cells.CtBP1参与人类多药耐药癌细胞中MDR1基因的转录激活。
Biochem Pharmacol. 2007 Sep 15;74(6):851-9. doi: 10.1016/j.bcp.2007.06.017. Epub 2007 Jun 17.
6
Loss of maspin expression contributes to a more invasive potential in malignant melanoma.乳腺丝抑蛋白表达缺失促使恶性黑色素瘤具有更强的侵袭潜能。
Pigment Cell Res. 2007 Apr;20(2):112-9. doi: 10.1111/j.1600-0749.2007.00363.x.
7
Transcriptional regulation by C-terminal binding proteins.C末端结合蛋白的转录调控
Int J Biochem Cell Biol. 2007;39(9):1593-607. doi: 10.1016/j.biocel.2007.01.025. Epub 2007 Feb 4.
8
OCIA domain containing 2 is highly expressed in adenocarcinoma mixed subtype with bronchioloalveolar carcinoma component and is associated with better prognosis.含OCIA结构域蛋白2在具有细支气管肺泡癌成分的腺癌混合亚型中高表达,且与较好的预后相关。
Cancer Sci. 2007 Jan;98(1):50-7. doi: 10.1111/j.1349-7006.2006.00346.x.
9
Autotaxin stimulates urokinase-type plasminogen activator expression through phosphoinositide 3-kinase-Akt-nuclear [corrected] factor kappa B signaling cascade in human melanoma cells.自分泌运动因子通过磷酸肌醇3激酶-蛋白激酶B-核因子κB信号级联反应刺激人黑色素瘤细胞中尿激酶型纤溶酶原激活剂的表达。
Melanoma Res. 2006 Oct;16(5):445-52. doi: 10.1097/01.cmr.0000232293.14408.a4.
10
Role of the C-terminal binding protein PXDLS motif binding cleft in protein interactions and transcriptional repression.C末端结合蛋白PXDLS基序结合裂隙在蛋白质相互作用和转录抑制中的作用。
Mol Cell Biol. 2006 Nov;26(21):8202-13. doi: 10.1128/MCB.00445-06. Epub 2006 Aug 28.